Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma
Simon Jasinski‐Bergner, Robert Stoehr, Juergen Bukur, et al.
OncoImmunology (2015) Vol. 4, Iss. 6, pp. e1008805-e1008805
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis
Sarah Nersesian, Sarah L. Schwartz, Stephanie R. Grantham, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100930-100930
Open Access | Times Cited: 142
Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
Stefan B. Eichmüller, Wolfram Osen, Ofer Mandelboim, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 138
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin, Wei‐Hua Yan
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 782-791
Open Access | Times Cited: 120
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
Fabio Morandi, Roberta Rizzo, Enrico Fainardi, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-14
Open Access | Times Cited: 118
The role of the miR‐148/‐152 family in physiology and disease
Michael Friedrich, Katharina Pracht, Mir‐Farzin Mashreghi, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 12, pp. 2026-2038
Open Access | Times Cited: 108
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
Esther Schwich, Vera Rebmann, Rafael Tomoya Michita, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
Hany A. Omar, Ahmed T. El‐Serafi, Fatema Hersi, et al.
FEBS Journal (2019) Vol. 286, Iss. 18, pp. 3540-3557
Open Access | Times Cited: 77
Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
Э. А. Брага, М. В. Фридман, В. И. Логинов, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 76
The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer
Hajar Alemohammad, Basira Najafzadeh, Zahra Asadzadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112516-112516
Open Access | Times Cited: 70
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
Siyuan Wang, Jiaxin Wang, Yu Xia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer
Steffen Grampp, James L. Platt, Victoria Lauer, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 71
HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
miR-146b antagomir–treated human Tregs acquire increased GVHD inhibitory potency
Yunjie Lu, Keli L. Hippen, Amanda L. Lemire, et al.
Blood (2016) Vol. 128, Iss. 10, pp. 1424-1435
Open Access | Times Cited: 62
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
Michael Friedrich, Simon Jasinski‐Bergner, Maria‐Filothei Lazaridou, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 10, pp. 1689-1700
Closed Access | Times Cited: 62
HLA-E expression and its clinical relevance in human renal cell carcinoma
Barbara Seliger, Simon Jasinski‐Bergner, Dagmar Quandt, et al.
Oncotarget (2016) Vol. 7, Iss. 41, pp. 67360-67372
Open Access | Times Cited: 57
Molecular mechanisms of HLA class I‐mediated immune evasion of human tumors and their role in resistance to immunotherapies
Barbara Seliger
HLA (2016) Vol. 88, Iss. 5, pp. 213-220
Closed Access | Times Cited: 50
Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease
Keli L. Hippen, Michaël Loschi, Jemma Nicholls, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 50
NK cells in renal cell carcinoma and its implications for CAR-NK therapy
Xinwei Li, Yuanpeng Zhang, Yuzhong Ye, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Identification and Characterization of the RNA Modifying Factors PUS7 and WTAP as Key Components for the Control of Tumor Biological Processes in Renal Cell Carcinomas
Tim Hohmann, Urszula Grabiec, Faramarz Dehghani, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 266-266
Open Access
Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma
Simon Jasinski‐Bergner, Adi Reches, Robert Stoehr, et al.
Oncotarget (2016) Vol. 7, Iss. 18, pp. 26866-26878
Open Access | Times Cited: 46
RNA-Sequenzierung zur Analyse Epstein-Barr-Virus-codierter microRNAs
Tim Hohmann, Simon Jasinski‐Bergner
BIOspektrum (2025) Vol. 31, Iss. 1, pp. 45-48
Open Access
Cellular and secretome profiling uncover immunological biomarkers in the prognosis of renal cell carcinoma patients
Le Tong, Veronika Kremer, Shiyong Neo, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin
Simon Jasinski‐Bergner, Maximilian Büttner, Dagmar Quandt, et al.
Obesity Facts (2017) Vol. 10, Iss. 6, pp. 569-583
Open Access | Times Cited: 37
Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma
Andreas Kahlmeyer, Christine Stöhr, Arndt Hartmann, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 743-743
Open Access | Times Cited: 34
Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo
Patrick Maschmeyer, Georg Petkau, Francesco Siracusa, et al.
Journal of Autoimmunity (2017) Vol. 89, pp. 41-52
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top